Agah Ramtin

SEC source: 0001493152-26-015591 · ownership.xml · derivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 621,727

Underlying: Common Stock · 621,727 shares

Expires not disclosed

F1 · derivative.exercise_date: On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 621,727 shares of the Issuer's common stock (319,073 shares of which are underlying incentive stock options and 302,654 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036.

F1 · derivative.expiration_date: On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 621,727 shares of the Issuer's common stock (319,073 shares of which are underlying incentive stock options and 302,654 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036.

SEC source: 0001493152-26-003181 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 798,460

F1 · shares: Reflects open market purchases of the Issuer's securities.

F2 · price: Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.995 to $1.00.

SEC source: 0001493152-26-000255 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 788,460

F1 · shares: Reflects open market purchases of the Issuer's securities.

SEC source: 0001493152-26-000157 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 778,665

F1 · shares: Reflects open market purchases of the Issuer's securities.

F2 · price: Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.825 to $0.873.

SEC source: 0001493152-25-028057 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 778,460

F1 · shares: Reflects an open market purchase of the Issuer's securities.

SEC source: 0001493152-25-026516 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 766,460

F1 · shares: Reflects open market purchases of the Issuer's securities.

SEC source: 0001493152-25-024875 · ownership.xml · nonDerivative · entry 2

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 756,460

F1 · shares: Reflects open market purchases of the Issuer's securities.

SEC source: 0001493152-25-024875 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 744,460

F1 · shares: Reflects open market purchases of the Issuer's securities.

SEC source: 0001641172-25-017833 · ownership.xml · derivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,636

Underlying: Common stock · 63,636 shares

Expires not disclosed

F1 · derivative.exercise_date: Represents an award of 63,636 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the "Plan") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025. The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035.

F1 · derivative.expiration_date: Represents an award of 63,636 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the "Plan") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025. The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035.

SEC source: 0001641172-25-014212 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 734,460

F1 · shares: Reflects open market purchases of the Issuer's securities.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001641172-25-014112 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 713,460

F1 · kind: On April 22, 2025, the reporting person made a bona fide gift of an aggregate of 400,000 shares of the Issuer's common stock to trusts for the benefit of the reporting person's children. The reporting person is not a trustee or beneficiary of such trusts and therefore no longer has a beneficial ownership interest in the subject shares.

SEC source: 0001641172-25-005139 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,113,460

F1 · shares: Reflects open market purchases of the Issuer's securities.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001641172-25-005106 · ownership.xml · derivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,542

Underlying: Common Stock · 254,542 shares

Expires not disclosed

F1 · derivative.exercise_date: On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted a non-qualified stock option to purchase up to 254,542 shares of the Issuer's common stock, with such option vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on April 14, 2035..

F1 · derivative.expiration_date: On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted a non-qualified stock option to purchase up to 254,542 shares of the Issuer's common stock, with such option vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on April 14, 2035..

SEC source: 0001641172-25-003951 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,098,460

F1 · shares: Reflects open market purchases of the Issuer's securities.

SEC source: 0001641172-25-003631 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,078,460

F1 · shares: Reflects open market purchases of the Issuer's securities.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001641172-25-003364 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,048,460

F1 · shares: Reflects open market purchases of the Issuer's securities.

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.825 to $0.8499, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F3 · balance_after: Includes 975,000 shares, which are held of record by the reporting person currently and were held of record by the Mars16 Nevada Non-Grantor Trust Dtd 01/19/2016 and reported as indirectly held by the reporting person previously.

F3 · ownership.direct: Includes 975,000 shares, which are held of record by the reporting person currently and were held of record by the Mars16 Nevada Non-Grantor Trust Dtd 01/19/2016 and reported as indirectly held by the reporting person previously.

SEC source: 0001493152-24-004372 · ownership.xml · derivative · entry 2

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,983

Underlying: Common Stock · 40,983 shares

Expires not disclosed

F1 · price: Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. These warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029.

F1 · derivative.exercise_date: Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. These warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029.

F1 · derivative.expiration_date: Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. These warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029.

SEC source: 0001493152-24-004372 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,460

F1 · price: Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. These warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029.

SEC source: 0001493152-24-003520 · ownership.xml · derivative · entry 2

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,132

Underlying: Common Stock · 125,132 shares

Expires not disclosed

F2 · derivative.exercise_date: On January 19, 2024, the Reporting Person received a nonqualified stock option grant for 125,132 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January 19, 2034.

F2 · derivative.expiration_date: On January 19, 2024, the Reporting Person received a nonqualified stock option grant for 125,132 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January 19, 2034.

SEC source: 0001493152-24-003520 · ownership.xml · derivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,424

Underlying: Common Stock · 28,424 shares

Expires not disclosed

F1 · derivative.exercise_date: On January 19, 2024, the Reporting Person was awarded a stock bonus of 28,424 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the "Plan"). These shares were fully vested upon issuance to the Reporting Person, and expire on January 19, 2034.

F1 · derivative.expiration_date: On January 19, 2024, the Reporting Person was awarded a stock bonus of 28,424 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the "Plan"). These shares were fully vested upon issuance to the Reporting Person, and expire on January 19, 2034.

SEC source: 0001493152-23-009504 · ownership.xml · derivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2033-03-15

F1 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on January 1, 2023.

SEC source: 0001493152-22-016226 · ownership.xml · nonDerivative · entry 3

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,477

SEC source: 0001493152-22-016226 · ownership.xml · nonDerivative · entry 2

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 975,000

F1 · ownership.nature: The shares are held of record by the Mars16 Nevada Non-Grantor Trust Dtd 01/19/2016.

SEC source: 0001493152-22-016226 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,295

SEC source: 0001209191-22-018469 · doc4.xml · derivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,398

Underlying: Common Stock · 21,398 shares

Expires 2032-03-10

F1 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on September 26, 2021.

SEC source: 0001209191-21-059161 · doc4.xml · derivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,203

Underlying: Common Stock · 52,203 shares

Expires 2031-09-29

F1 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on September 26, 2021.

SEC source: 0001493152-22-017155 · ownership.xml · derivative · entry 3

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,295

Underlying: Common Stock · 1,295 shares

Expires 2026-08-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares of Common Stock underlying the warrant are immediately exercisable.

SEC source: 0001493152-22-017155 · ownership.xml · derivative · entry 2

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,295 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share.

F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share.

F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share.

SEC source: 0001493152-22-017155 · ownership.xml · nonDerivative · entry 1

Agah Ramtin · CIK 0001862617 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 976,295

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share.